SEARCH

SEARCH BY CITATION

References

  • Binnie, C. D., van Emde Boas, G. S., Land, G. S., Meyer, J. W. A., Overweg, J. & VAN Wieringen, A. (1984). Preliminary single dose studies of a potential new antiepileptic drug, BW430C, in epileptic patients. Epilepsia, 25, 656.
  • Bittencourt, P. R. M., Gresty, M. A. & Richens, A. (1983). Quantitative assessment of smooth-pursuit eye movements in healthy epileptic subjects. J. Neurol. Neurosurg. Psych., 43, 11191124.
  • Bittencourt, P. R. M. & Richens, A. (1981a). Serum drug concentrations and effects on smooth-pursuit and saccadic eye movements. Proceedings of an International Congress of Neurophysiology, Kyoto, Japan.
  • Bittencourt, P. R. M., Smith, A. T., Lloyd, D. S. L., Richens, A. (1982a). Determination of smooth pursuit eye movement velocity in humans by computer. Electroencephalography and Clinical Neurophysiology, 54, 399405.
  • Bittencourt, P. R. M., Wade, P., Smith, A. T. & Richens, A. (1981b). The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. Br. J. clin. Pharmac., 12, 523533.
  • Bittencourt, P. R. M., Wade, P., Smith, A. T., Richens, A. (1982b). Benzodiazepines impair smooth pursuit eye movements. Br. J. clin. Pharmac., 15, 259262.
  • Booker, H. E., Matthews, C. G. & Slaby, A. (1967). Effects of diphenylhydantoin on selected physiological and psychological measures in normal adults. Neurology, 17, 949.
  • Cohen, A. F., Fowle, A. S. E., Land, G. S. & Bye, A. E. (1984a). BW430C: a new anticonvulsant. Pharmacokinetics in normal man. Epilepsia, 25, 656.
  • Cohen, A. F., Hamilton, M., Strutt, A., Philipson, R. & Peck, A. W. (1984b). A new H1-receptor antagonist, BW825C: effects on tracking, reaction time and subjective ratings. Br. J. clin. Pharmac., 17, 647P.
  • Forney, R., Backmann, K. & Voeller, K. (1983). Monitoring phenytoin in plasma ultra filtrates of pediatric epilepsy patients. Proceedings II World Conference on Clinical Pharmacology & Therapeutics..
  • Fuchs, A. F. & Kaneko, C. R. S. (1981). A brain stem generator for saccadic eye movements. Trends in Neurosciences, November, 283286.
  • Gannaway, D. J. & Mawer, G. E. (1981). Serum phenytoin concentration and clinical response in patients with epilepsy. Br. J. clin. Pharmac., 12, 833839.
  • Haward, L. (1973). Effects of DPH (sodium diphenylhydantoin) upon concentration in pilots. Revue de Medecine Aeronautique et Spatiale, 46, 372.
  • Houghton, G. W., Latham, A. N. & Richens, A. (1973). Difference in the central actions of phenytoin and phenobarbitone in man, measured by critical flicker fusion threshold. Eur. J. clin. Pharmac., 6, 5760.
  • Hunt, P., Husson, J. M. & Raynaud, J. P. (1979). A radioreceptor assay for benzodiazepines. J. Pharm. Pharmac., 31, 448451.
  • Idestrom, C. M., Schalling, D., Carlquist, U. & Sjoqvist, F. (1972). Acute effects of diphenylhydantoin in relation to plasma levels. Psychol. Med., 2, 111120.
  • Jawad, S., Oxley, J. R., Yuen, W. C. & Richens, A. (1985). Reduction of interictal electroencephalographic spikes by lamotrigine in epileptic patients. Br. J. clin. Pharmac., 20, 287P288P.
  • Jones, G. L., Wimbush, G. H. & McIntosh, W. E. (1983). Phenytoin: basic and clinical pharmacology. Medicinal Research Reviews, 3, 383434.
  • McGregor, A. R., Crookall-Greening, J. O., Landon, J. & Smith, D. S. (1978). Polarisation fluro-immunoassay of phenytoin. Clin. Chim. Acta, 83, 161166.
  • Miller, A. A., Sawyer, D. A., Roth, B., Wheatley, P. L. Leach, M. J. & Lamb, R. J. (1984). Anticonvulsant studies on BW430C a novel potential anticonvulsant. Epilepsia, 25, 655.
  • Nicholson, A. N. (1979). Performance studies with diazepam and its hydroxylated metabolites. Br. J. clin. Pharmac., 8, 38S42S.
  • Norris, H. (1971). The action of sedatives on brain stem oculomotor systems in man. Neuropharmac., 10, 181191.
  • Riker, W. K., Downes, H., Olsen, G. D. & Smith, B. (1978). Conjugate lateral gaze nystagmus and free phenytoin concentrations in plasma: lack of correlation. Epilepsia, 19, 9398.
  • Robinson, D. A. (1968). Eye movement control in primates. Science, 162, 1219.
  • Rothenberg, S. J. & Selkoe, D. (1981). Specific oculomotor deficits after diazepam I saccadic eye movements. Psychopharmacology, 74, 232236.
  • Shah, V. P., Prasad, V. K., Freeman, C., Skelly, J. P. & Carana, B. E. (1983). In vitro-in vivo bioequivalence standard for 100 mg phenytoin sodium capsules. J. pharm. Sci., 309, 72.
  • Schmidt, D. & Kupferberg, H. J. (1975). Diphenylhydantoin, phenobarbital and primodone in saliva, plasma and cerebrospinal fluid. Epilepsia, 16, 735741.
  • Scott, D. B., Fagan, D. & Tiplady, B. (1982). Effects of amitriptyline and zimelidine in combination with ethanol. Psychopharmacology, 76, 209211.
  • Smith, A. T., Bittencourt, P. R. M., Lloyd, D. S. L. & Richens, A. (1981). An efficient technique for determining characteristics of saccadic eye movements using a mini computer. J. Biomed. Engng, 3, 39.
  • Stephens, J. H., Shaffer, J. W. & Brown, C. C. (1967). A controlled comparison of the effects of diphenylhydantoin and placebo on mood and psychomotor functioning in normal volunteers. J. clin. Pharmac., 7, 543.
  • Tedeschi, G., Bittencourt, P. R. M., Smith, A. T. & Richens, A. (1982). Specific oculomotor deficits after amylobarbitone. Psychopharmac., 79, 187189.
  • Tedeschi, G., Smith, A. T., Dhillon, S. & Richens, A. (1983). Rate of entrance of benzodiazepines into the brain determined by eye movement recording. Br. J. clin. Pharmac., 15, 103105.